Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"140 - Specific philosophical schools"
product_txtF_mv:"National Center for Biotechnology Information"
Showing
1
-
20
of
104
Search:
''
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Long-term use of ranibizumab for the treatment of age-related macular degeneration : a review of the clinical and cost-effectiveness and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
Read Now
2
Storage, handling, and administration of expressed human breast milk : a review of guidelines
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
3
Non-invasive methods for diagnosis and monitoring of liver fibrosis in patients with chronic hepatitis B and C : a review of diagnostic accuracy, clinical effectiveness, cost-effec...
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
4
Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have r...
Published 2014
Canadian Agency for Drugs and Technologies in Health
Read Now
5
Patient group input submissions: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
6
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
7
Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
8
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
9
Omalizumab treatment for adults and children with allergic asthma : a review of the clinical effectiveness, cost-effectiveness, and guidelines
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
10
Reslizumab (Cinqair)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
11
Human growth hormone treatment for adult growth hormone deficiency : a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines
Published 2015
CADTH Rapid Response Service
Read Now
12
Idarucizumab for reversing anticoagulation in adults treated with dabigatran : a review of the clinical effectiveness, cost-effectiveness, and guidelines
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
13
Human growth hormone treatment for Prader-Willi syndrome in adolescent and adult patients: clinical evidence, safety, and guidelines
Published 2015
CADTH Rapid Response Service
Read Now
14
Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness
by
Young, Calvin
,
Campbell, Kaitryn
Published 2019
CADTH
Read Now
15
Immune checkpoint inhibitors for classical Hodgkin lymphoma in brentuximab vedotin-naïve patients : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Williams, D.
,
Gray, Casey
,
Picheca, Lory
Published 2019
CADTH
Read Now
16
HPV testing for primary cervical cancer screening : a health technology assessment
by
Chao, Yi-Sheng
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
17
Pharmacoeconomic report: Ofatumumab (Kesimpta) (Novartis Pharmaceuticals Canada Inc.) : indication: multiple sclerosis, relapsing-remitting
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
18
Clinical review report: Ofatumumab (Kesimpta) (Novartis Pharmaceuticals Canada Inc.) : indication: multiple sclerosis, relapsing-remitting
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
19
Clinical and economic review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
20
Seasonal influenza immunization of health care workers for the prevention of influenza in patients : a review of the clinical effectiveness
by
Seal, Kelsey
,
Spry, Carolyn
Published 2017
Canadian Agency for Drugs and Technologies in Health
1
2
3
4
5
6
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 140 - Specific philosophical schools
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
610 - Medicine & health
40
330 - Economics
29
700 - The arts; fine & decorative arts
18
Language
English
104
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
19
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
9
Chao, Yi-Sheng
3
Spry, Carolyn
3
Argáez, Charlene
2
more ...
Campbell, Kaitryn
2
Gray, Casey
2
Grobelna, Aleksandra
2
Marchand, Dave K.
2
Picheca, Lory
2
Seal, Kelsey
2
Wells, Charlotte
2
Williams, D.
2
Young, Calvin
2
Adcock, Lorna
1
Edge, Rob
1
La Fleur, Philip
1
Multiple Sclerosis Society of Canada
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22140+-+Specific+philosophical+schools%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&type=AllFields
Send by Email
×
Loading...